The South Korean government is planning to invest three billion won for three years to come in order to help small and venture firms develop and commercialize technology related to bioplastics.These days, white biotechnology is emerging as a solution to plastic wastes and carbon emissions. The techn
The author is an analyst of NH Investment & Securities. He can be reached at hwdoh@nhqv.com. -- Ed. From 2021, SEC’s foundry business is to fully arrive as a new growth driver. Helped by slowing supply expansion and increasing data center demand, memory supply-demand conditions should also improve i
The authors are analysts of Shinhan Investment Corp. They can be reached at shawn1225@shinhan.com and jhwon@shinhan.com, respectively. – Ed. USD300mn technology licensing agreement for DLK-1 ADC candidate signed with Pyxis OncologyLegoChem Biosciences disclosed on Dec. 2 that it signed a USD300mn (K
Samsung Biologics has decided to stop the research and development (R&D) activities of Archigen Biotech, a joint venture with AstraZeneca.Archigen Biotech, launched in 2014, has been developing “SAIT101,” a biosimilar of Rituxan (component name: Rituximab). Rituxan is a biopharmaceutical product of
Mirae Asset Management has won a lawsuit against China's Anbang Insurance over the acquisition of 15 luxury U.S. hotels worth $5.8 billion.In a regulatory filing on Dec. 1, the company said that the Delaware Chancery Court ruled on Nov. 30 (local time) that Anbang Insurance must return a deposit
SK Telecom (SKT) will establish an integrated security company by merging its subsidiaries SK Infosec and ADT Caps.SK Infosec and Life and Security Holdings (LSH), the parent company of ADT Caps, each held a board of directors meeting recently and approved the merger.SK Infosec and LSH will merge wi
BlueVisor, a member company of Born2Global Centre, placed second in the latest Fintech Unicorn Battle in Asia, receiving recognition for its technological prowess and business viability.The Fintech Unicorn Battle in Asia is a global pitch competition organized by Startup.Network. It provides an oppo
Korea’s major biotech and healthcare companies, including Samsung Biologics and Celltrion, will invest a total of 10 trillion won by 2023.The Ministry of Trade, Industry and Energy announced its strategy to promote the biotech and healthcare industry and strengthen its technological capabilities at
Korea Exchange and the Korea Listed Companies Association announced on Nov. 18 that 590 KOSPI-listed companies recorded a combined operating profit of 25,628.5 billion won in the third quarter of this year, up 48.7 percent from a year ago. “Although it is true that the profit was too small in Q3 201
Samsung Biologics has recently signed an MOU with Sartorius, a German life science company, to further strengthen the supply chain for biomedicines.Sartorius has recently announced a plan to invest US$100 million in South Korea's bio cluster, Songdo, to build a bio-process manufacturing facility
Samsung SDS has been positioned in the ‘2020 Gartner Magic Quadrant for Industrial IoT Platforms.’ Samsung SDS is one of the 4 new entrants and it is the only Korean company among 18 Industrial IoT (IIoT) platform providers in the report.Magic Quadrant is an annual report published by Gartner that e
The Korea Institute for Advancement of Technology announced on Nov. 15 that South Korea’s top 50 R&D investors included eight pharmaceutical and biotechnology companies last year. This is noteworthy in that pharma and biotech companies’ sales are smaller than those of enterprises in the other sector
The author is an analyst of NH Investment & Securities. They can be reached at jaemin.ahn@nhqv.com. -- Ed. 5G service quality improvingIn Apr 2021, it will become two years since 5G services were first introduced in Korea. Compared to 4G LTE services, the pace of subscriber growth appears slower for
U.S. President-elect Joe Biden said on his election campaign website that he will put Americans into making various important products such as semiconductors. This is part of a U.S. manufacturing revival plan laid out by Biden.Under the economic slogan "Made in All of America," Biden will make effor
As digital conversion accelerates after the spread of the new coronavirus, investments in new semiconductor production facilities are expected to continue to grow.Semiconductor Equipment and Materials International (SEMI) announced on Nov. 5 that investment in 300mm wafer fabs in 2020 will increase
Korea Exchange decided on Nov. 4 to delist Kolon TissueGene. Previously, it turned out that its Invossa-K, the world’s first gene therapy product for osteoarthritis patients, contains renal cells instead of chondrocytes and the Ministry of Food and Drug Safety canceled its approval in May last year
ViGenCell, a biotechnology affiliate of Boryung Pharmaceutical that specializes in immune cell therapy technologies, has launched a scientific advisory committee composed of immunological and clinical research experts to accelerate the development of treatments for intractable diseases and strengthe
POSCO has joined hands with KT Corp., South Korea’s major telecom company, and MYSTECH Co., a manufacturer of eco-friendly street facilities, to build a ‘smart green city.'The three companies signed a business agreement on Oct. 21.Street facilities refer to various facilities installed on the st
CJ CheilJedang will make a foray into the white biotechnology market based on its competitive fermentation technology. White biotechnology uses plants and other biological resources to produce materials such as industrial materials or bio-fuels. Its importance is rapidly growing as it produces mater
Samsung Electronics' IoT platform SmartThings will be applied to Mercedes-Benz cars. Samsung Electronics acquired SmartThings, a U.S. venture company specializing in IoT platforms, for about US$200 million in 2014 and is currently operating an app with the same name as that of the company. When